CancerWorld Issue #110 (December) is Live
25 Posts Not to Miss from ASH 2025
Paco Arango: "Casa Aladina" - the First Comprehensive Support Day Center in Europe for Children with Cancer
Final Results of CARES-310 Study: Camrelizumab + Rivoceranib vs Sorafenib in Unresectable HCC
10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily
MajesTEC-3 trial: Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
Alicia Zhou: The Mission-Driven Biologist Building the Future of Immunotherapy
Prof. Ruben Mesa Recognized with the 2025 ASH Ernest Beutler Lecture and Prize
The Digestive Oncology Autumn Symposium, Edition 2025, is scheduled for the afternoon of Tuesday, December 16, 2025, at Salons De Romree in Grimbergen, Belgium. The event will begin with a lunch from 1:00 PM to 2:00 PM, followed by the scientific presentations from 2:00 PM to 5:40 PM. This annual congress is presented by The […]
The State of AI in Precision Oncology 2025 is the third annual, free virtual summit hosted by the journal AI in Precision Oncology, aiming to assess the current evolution of medicine driven by Artificial Intelligence, specifically within the field of oncology. Scheduled for Tuesday, Dec 16, 2025 at 8:00 PM - Wednesday, Dec 17, 2025 […]
The EORTC Lung Cancer Group Multidisciplinary Webinar on Clinical Trials in Stage III NSCLC is scheduled for December 17, 2025, at 18:00 CET. This free, open-to-all online event will feature […]
The SITC Webinar on Bispecifics and T cell Engagers: Practical Strategies for Recognizing and Managing Toxicities is a virtual, multi-stakeholder event scheduled for December 17, 2025, from 1:00 p.m. to […]
"Going Full TILt: challenges, successes, and coordination with administering TIL therapy" is an upcoming "Rx-cited: Clinical Conundrums" roundtable organized by the ASTCT Pharmacy SIG Research Subcommittee and New Practitioner Task […]
The 2026 ASCO Gastrointestinal Cancers Symposium will take place from January 8–10, 2026, at Moscone West in San Francisco, CA, as well as online. This annual event gathers oncology professionals from around the world to explore the latest developments in GI cancer treatment, research, and patient care. Featuring cutting-edge scientific presentations and multidisciplinary discussions, the […]
The Highlights of ASH in North America is a two-day program offered by the American Society of Hematology (ASH) in multiple locations to explore and discuss the most influential and novel research presented at the latest ASH Annual Meeting. The program is designed to allow hematology leaders and experts to connect in person, learn how […]
The MASCC Webinar “ADCs and Mucositis: From Mechanism to Care” on January 15, 2026, at 8:00 PM UTC+4 will explore the therapeutic potential and toxicity of antibody-drug conjugates (ADCs), with […]
The ESMO Preceptorship on Breast Cancer 2026: Milan is a two-day educational course that provides oncologists with a thorough understanding of breast cancer management, covering topics from diagnosis to treatment, based on current standards of care in a multidisciplinary setting. The preceptorship will take place from January 16–17, 2026, in Milan, Italy. The course is […]
The Cancer Immunotherapy Winter School, hosted by the Society for Immunotherapy of Cancer (SITC), is a hybrid program taking place in Boston and virtually from February 16–18, 2026, with the in-person meeting held at The Westin Copley Place, Boston. The school is tailored for early-to-mid career scientists and clinicians who are new to the field, […]
The 2nd Annual Cleveland Clinic Cancer Conference: Innovations in Multidisciplinary Care will be held from January 16 to 18, 2026, in Hollywood, Florida. This premier event brings together a diverse range of oncology professionals including medical oncologists, hematologists, radiation oncologists, and other healthcare providers to explore the latest developments in cancer diagnosis, treatment, and supportive […]
The European Association for Cancer Research (EACR) conference, "Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy," is a Virtual Event scheduled for January 20-21, 2026. This conference explores a paradoxical and radically different approach to cancer therapy: instead of inhibiting the signals that drive cancer, it focuses on the deliberate hyper-activation of oncogenic […]